Obinutuzumab Injection

Anter

• Ma mua o ka loaʻa ʻana o ka pahu kui obinutuzumab,
• Hoʻokumu paha ka pahu o Obinutuzumab i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kēia ʻōuli a hele ʻole paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT a i ʻole PAUAHI, e kāhea koke i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia.

Ua hele a maʻi paha ʻoe i ka maʻi hepatitis B (kahi maʻi i hoʻopili ʻia i ke akepaʻa a e hōʻeha paha i ka ate) akā ʻaʻohe o nā ʻōuli o ka maʻi. I kēia hihia, hoʻonui paha ka pīkī obinutuzumab i ka makaʻu e lilo i kāu maʻi i mea koʻikoʻi a hoʻoweliweli paha i ke ola a ulu ʻoe i nā ʻōuli. E haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe i ka maʻi maʻi virus hepatitis B. E kauoha aku kāu kauka i kahi hoʻokolohua koko e ʻike inā loaʻa iā ʻoe kahi maʻi maʻi hepatitis B hana ʻole. Inā pono, hiki i kāu kauka ke hāʻawi iā ʻoe i lāʻau e mālama ai i kēia maʻi. E nānā pū kāu kauka iā ʻoe no nā hōʻailona o ka maʻi hepatitis B i ka manawa a no kekahi mau mahina ma hope o kāu mālama ʻana me obinutuzumab. Inā ʻoe e ʻike i kekahi o nā ʻōuli ma hope a i ʻole a ma hope paha o kāu lapaʻau ʻana, e kāhea koke i kāu kauka: luhi nui, melemele o ka ʻili a i ʻole nā ​​maka, nalo ʻole ka makemake, kahoʻi a i ʻole ka luaʻi, ʻeha o ka ʻōpū, a me ka mimi ʻeleʻele.

ʻO kekahi poʻe i loaʻa ka obinutuzumab i hoʻomohala i ka leukoencephalopathy multifocal holomua (PML; kahi maʻi laha ʻole o ka lolo i hiki ʻole ke mālama ʻia, pale ʻia, a hoʻōla ʻia a ʻo ka mea maʻamau ka make a i ʻole ke kīnā koʻikoʻi) i kā lākou mālama ʻia.Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e kāhea koke aku i kāu kauka: nā loli hou a ʻole ʻole i ka noʻonoʻo a huikau paha, ka palaho, ka nalo ʻana o ke kaulike, ka paʻakikī e kamaʻilio a me ka hele wāwae paha, nā loli hou a ʻole hikiwawe i ka hihiʻo, a i ʻole nā ​​hōʻailona ʻē aʻe e ulu koke.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha kāu kauka i kekahi mau hoʻokolohua e nānā i ka pane o kou kino i ka inikua obinutuzumab.

E kamaʻilio me kāu kauka e pili ana i nā pilikia o ka loaʻa ʻana o ka inikua obinutuzumab.

Hoʻohana ʻia ka injection Obinutuzumab me ka chlorambucil (Leukeran) e mālama ai i ka leukemia lymphocytic mau (CLL; kahi ʻano maʻi ʻaʻai o nā hunaola keʻokeʻo). Hoʻohana wale ʻia ia a i ʻole me ka bendamustine (Bendeka, Treanda) a i ʻole nā ​​lāʻau chemotherapy (s) e mālama ai i ka lymphoma non-Hodgkin follicular (NHL; kahi maʻi kōkō e ulu lohi ana) i ka poʻe e hoʻomaka ana i ka lapaʻau a i ʻole ua hoʻi ka maʻi a hoʻi ʻaʻole hoʻomaikaʻi ma hope o ka loaʻa ʻana o nā lāʻau chemotherapy ʻē aʻe. ʻO ka injection ʻo Obinutuzumab i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ka luku ʻana i nā hunaola maʻi ʻaʻai.

Hele mai ʻo ka inikua ʻo Obinutuzumab ma ke ʻano he hopena (wai) e hoʻohui ʻia i ka wai a hoʻokomo ʻino ʻia (i loko o kahi aa) e ke kauka a kahu hānai paha i kahi keʻena olakino a i ʻole haukapila. E koho kāu kauka i kahi papa manawa e hāʻawi iā ʻoe i ka injection obinutuzumab me nā lāʻau ʻē aʻe e ʻoi aku ka maikaʻi e mālama ai i kāu maʻi.

Pono paha kāu kauka e hoʻopau a hoʻopau paha i kāu lāʻau inā ʻike ʻoe i kekahi mau hopena ʻaoʻao. E hāʻawi aku kāu kauka iā ʻoe i nā lāʻau ʻē aʻe e pale a mālama i kekahi mau hopena ʻē aʻe ma mua o kou loaʻa ʻana i kēlā me kēia lāʻau o ka inikopa obinutuzumab. E haʻi i kāu kauka a kahu hānai inā ʻike ʻoe i kekahi o kēia mau mea i loko a i ʻole ma loko o 24 mau hola ma hope o kou loaʻa ʻana i ka obinutuzumab: ʻōpōpō, ʻālohilohi, maʻule, puʻuwai wikiwiki, ʻeha o ka umauma, paʻakikī hanu, pehu o ka ʻāʻī, nausea, luaʻi, luhi, pākī, ʻulaʻula ʻulaʻula o ka maka, ʻāʻī, a i ʻole ka umauma luna, ʻeha poʻo, ʻalā, a me ke kuni.

E pono e haʻi aku i kāu kauka i kou ʻano i kou wā e mālama ai me ka inikua obinutuzumab.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka pahu kui obinutuzumab,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka obinutuzumab, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka inikua obinutuzumab. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E ʻōlelo pono i nā lāʻau no ke kahe kiʻekiʻe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa paha iā ʻoe ka maʻi puʻuwai a i ʻole puʻupuʻu. E haʻi aku i kāu kauka inā loaʻa kekahi ʻano maʻi i kēia manawa a i ʻole inā he maʻi paha kāu e hele ʻole a i ʻole kahi maʻi e hele a hele.
• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka loaʻa ʻana o ka inikua obinutuzumab, kāhea i kāu kauka.
• inā ke ʻokiʻoki nei ʻoe, e like me ke kaha ʻana o ka niho, e haʻi i ke kauka a i ʻole kauka niho paha ke loaʻa nei ʻoe i ka pahu kui obinutuzumab.
• ʻaʻohe o nā lāʻau āpau ke kamaʻilio ʻole ʻia me kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai ka obinutuzumab, kāhea koke aku i kāu kauka.

Hoʻokumu paha ka pahu o Obinutuzumab i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kēia ʻōuli a hele ʻole paha:

• ʻehaʻeha a ʻeha pū paha

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT a i ʻole PAUAHI, e kāhea koke i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia.

• ke kuni, ke anu, ka puʻu, ka ʻāʻī, a i ʻole nā ​​hōʻailona ʻē aʻe o ka maʻi
• kahe koko ʻole ʻana a palapū paha
• ʻeha o ka umauma, ʻeha pū, a me ke kuni
• hoʻemi i ke alapine urination a i ʻole ka nui

Hoʻokumu paha ka pahu o Obinutuzumab i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka inikua obinutuzumab.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Gazyva^®